Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for ?-Cells in a Mouse Model of Type 1 Diabetes.
Khera E, Zhang L, Roberts S, Nessler I, Sandoval D, Reiner T, Thurber GM. Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for ?-Cells in a Mouse Model of Type 1 Diabetes. J Nucl Med. 2019 11; 60(11):1635-1641.